LOGIN
Efficacy and safety of newer anticoagulants vs enoxaparin for thromboprophylaxis after TJA
September 2017
Efficacy and safety of newer anticoagulants vs enoxaparin for thromboprophylaxis after TJA
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
Safety and Efficacy of New Anticoagulants for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty: A Meta-Analysis
J Arthroplasty. 2017 Feb;32(2):645-652Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
18 randomized controlled trials were included in this meta-analysis evaluating the efficacy and safety of newer anticoagulants compared to enoxaparin in total knee and total hip arthroplasty. Anticoagulants evaluated included apixaban, dabigatran, fondaparinux, rivaroxaban, and edoxaban. The only newer anticoagulant which failed to demonstrate a significant reduction in VTE incidence relative to e...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.